Calculate your SIP ReturnsExplore


Days Range

Data is not available currently. Please check back later.

Data is not available currently. Please check back later.

About Alembic Pharmaceuticals

History of Alembic Pharmaceuticals Limited 

Incorporated in 2010, Alembic Pharmaceuticals Limited is involved in the manufacturing and trading Active Pharmaceutical Intermediates (API) and finished dosage formulations. The company started in 1904, with the manufacture of alcohol and tinctures in Vadodara. Later, in 1940, they started the production of vitamins, cough syrups, sulphur drugs and tonics. In 1961, the company inaugurated the Penicillin plant. In 1967, the company started bulk manufacturing of Vitamin B12, and later, in 1971, they manufactured Erythromycin, the first in India. This was followed by the launch of Althrocin. By 1997, Althrocin had become a top-selling brand in India. In 2001, the company started the production of Cephalosporin C. In 2011, the company was demerged from the Alembic Group and Alembic Pharmaceuticals Limited was listed as a separate company. In 2012, Alembic Pharmaceuticals Limited entered the dermatology division with 8 products. The next year, the company had its first Non-Disclosure Agreement (NDA) with a partner and started filing in Brazil, EU and Australia. In 2015, the company launched Aripiprazole, established front-end operations in the United States, and shifted to in-house marketing, In 2016, they had a JV with Orbicular – Aleor Dermaceutical Limited and started developing dermatology products for overseas markets. In 2017, they opened another manufacturing facility for oncology medicines. In 2018, Alembic Pharmaceuticals Limited’s Aleor’s dermatology facility got approval from the Food and Drug Administration (FDA). The next year i.e., in 2019, the company made another JV to enter the Chinese market. In 2020, the company’s products in the US market made $250 million in sales. As of March 2023, Alembic Pharmaceuticals Limited has 9 manufacturing plants and 2 R&D centres in India. They serve 33 states (including Union Territories) in India and 77 countries worldwide.

Business Segments of Alembic Pharmaceuticals Limited 

There are 3 primary business segments of the company, which are as follows:
  • India Formulations: Under this segment, the company develops and delivers speciality medicines that cater to various chronic and acute therapies. The therapies include dermatology, ophthalmology, dermatology, orthopaedic, cardiology, anti diabetic, anti infection, gynaecology, animal health, and more. They have an extensive product range featuring 185 brands.
  • International Generics: Under this segment, the company manufactures products and caters to its global partners.
  • Active Pharmaceutical Ingredients: Alembic Pharmaceuticals manufactures APIs for select formulation products under this segment.
As of March 31, 2023, the subsidiaries of Alembic Pharmaceuticals Limited are as follows:
  • Okner Realty LLC: This wholly-owned subsidiary of thecompany is engaged in real estate development. 
  • Alembic Pharmaceuticals Europe Ltd: This wholly-owned subsidiary of the company was established to expand its business in Europe.
  • Alnova Pharmaceuticals SA: This is a wholly-owned subsidiary of the company that was established to expand its business in Switzerland.

Key Personalities of Alembic Pharmaceuticals Limited

Pranav Amin, Managing Director  Pranav Amin has been the Managing Director of Alembic Pharmaceuticals Limited since 2016. He also heads the company’s international business unit. He drives the company through empowerment, involvement and autonomy.

Parent Organisation
Indian Private
Managing Director
Chirayu R Amin
NSE Symbol

Peer Comparision

StocksMarket Cap (cr)Market Price (₹)52 Week Low-High (₹)

Community Discussion

10th July 2024
0 Replies

10th July 2024
Alembic Pharmaceuticals Ltd-latest-market-updates-80916
0 Replies

Alembic Pharmaceuticals Ltd FAQs

Alembic Pharmaceuticals Ltd (APLLTD) share price as of July 15, 2024, on NSE is Rs 986.55 (NSE) and Rs 986.55 (BSE) on BSE.
Yes, You can buy Alembic Pharmaceuticals Ltd (APLLTD) shares by opening a Demat account with Angel One.
Alembic Pharmaceuticals Ltd (APLLTD) share can be bought through the following modes:
1. Direct investment: You can buy Alembic Pharmaceuticals Ltd (APLLTD) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Alembic Pharmaceuticals Ltd (APLLTD) shares.
The main business of Alembic Pharmaceuticals is to develop and manufacture generic pharmaceutical substances, intermediates, and pharmaceutical products.
The main promoters of Alembic Pharmaceuticals include Nirayu Limited, Alembic Limited, Chirayu Ramanbhai Amin, Malika Chirayu Amin, Pranav Chirayu Amin, Shaunak Chirayu Amin, Udit Chirayu Amin, Inaaya Shaunak Amin, Naintara Shaunak Amin, Ranvir Pranav Amin, and Samira Pranav Amin.
The main subsidiaries that come under Alembic Pharmaceuticals are Alembic Pharmaceuticals Inc., Alembic Global Holding SA, Alembic Pharmaceuticals Australia Pty Ltd, Alembic Pharmaceuticals Europe Ltd., Alnova Pharmaceuticals SA, Alembic Labs LLC, Alembic Pharmaceuticals Canada Ltd., and Genius LLC.
Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

Top Stocks

VIEW ALLView All Stocks

Top Gainers

VIEW ALLView All Stocks

Top Losers

VIEW ALLView All Stocks

Enjoy Zero Brokerage on Equity Delivery
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link
Open Free Demat Account!
Enjoy Zero Brokerage on Stock Investments.